SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000902664-23-005906
Filing Date
2023-12-18
Accepted
2023-12-18 16:15:53
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROTAGONIST THERAPEUTICS, INC. p23-2990sc13g.htm SC 13G 61411
2 EXHIBIT 99.1 p23-2990exhibit99_1.htm EX-99.1 6956
  Complete submission text file 0000902664-23-005906.txt   70114
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Subject) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89601 | Film No.: 231493920
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902
Business Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902 203-890-2000
Point72 Asset Management, L.P. (Filed by) CIK: 0001603466 (see all company filings)

IRS No.: 465064661 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G